Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released
National Institutes of Health (NIH) sent this bulletin at 01/29/2021 08:30 AM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
01/29/2021 08:00 AM EST
Single dose vaccine appears to be safe and effective at preventing moderate and severe COVID-19 in adults.